“Global Immunochemistry Reagents, Analyzers and Test Kits market set to grow to $34bn by 2024” says Visiongain report

01 October 2019
Pharma

Visiongain has launched a new pharma report Immunochemistry Reagents, Analyzers and Test Kits Market: Reagents and Test Kits, Analyzers, Disease Specific Tests, Rapid Tests, Drugs of Abuse/Toxicology Tests, Endocrinology Tests, Therapeutic Drug Monitoring Tests, Anemia/Vitamin Tests, Allergic Blood Tests, Autoimmune Diseases, Cardiac Markers, Infectious Diseases, Tumor Markers, Chemiluminescence Analyzers, ELISA Analyzers, Immunofluorescence Analyzers, Radioimmunoassay Analyzers.

Immunochemistry technologies have evolved significantly over the years and now offer critical testing in all areas. High incidences of cancer, infectious diseases and cardiovascular diseases globally will fuel the demand for better disease specific immunochemistry tests.

The lead analyst of the report commented "Established markets such as the US and Western Europe dominate the global immunochemistry market. However, these markets are restrained by reduced healthcare budgets and increased regulatory pressures on device development and approval, which now requires evidence of clinical cost-effectiveness before approval is given.

There is therefore more opportunity for market penetration and larger sales volumes in emerging countries, such as India and China, as these countries remain relatively under penetrated and their diagnostic testing markets offer huge opportunities, especially with the vast population pool."

Leading companies featured in the report include Abbott, bioMerieux, Danaher, Fujirebio, Ortho Clinical Diagnostics, Roche, Siemens, Sysmex Corporation, Thermo Fisher Scientific, Trivitron Healthcare Pvt. Ltd. and other companies.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 207 336 6100.

About Visiongain
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Biobanking Market Report 2021-2031

In clinical trials relating to COVID-19, COVID-19 biobanks will play an important role. These biobanks will play an instrumental role in future scientific studies on the emerging coronavirus (COVID-19) pandemic facing the world.

23 October 2020

Read

Visiongain Publishes Pharmaceutical Product Information Management System Market Report 2020-2030

Some of the major factors fuelling the growth of global market include significant advantages associated with PIM solutions and inclination towards centralized models among across pharma sector.

19 October 2020

Read

Visiongain Publishes Pulmonary/Respiratory Drug Delivery Market Report 2020-2030

The coronavirus outbreak has negatively impacted all the economies and industries across the globe. Hence, for the next 1-2 years, the global respiratory drug delivery market is expected to take a hit.

12 October 2020

Read

Visiongain Publishes Real-World Evidence (RWE) Solutions Market Report 2020-2030

We predict strong revenue growth through to 2030. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

02 October 2020

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever